Q: How did Sánchez Devanny build a solid reputation in healthcare law and how does this reputation translate into benefits for your clients in this sector?

A: We are a full-service law firm, offering legal services across all areas of the law, although we specialize in four key industries: automotive, retail, energy, and healthcare. We ensure that our attorneys and technical experts possess deep knowledge of industry-specific issues. Our approach ensures that whether we are advising on regulatory matters, intellectual property, taxes, labor, or corporate issues, our advisers are well-versed in the client’s company, industry, and regulatory framework. This approach allows us to speak the same language as our clients, understanding their challenges and providing tailored, effective advice.

Q: How is the regulatory framework surrounding the acquisition of medicines for the public sector expected to evolve in the next six years?

A: The outgoing administration attempted several different acquisition models, including hiring UNOPS. Despite increased spending, the system acquired fewer products. This imbalance between expenditure and volume is unacceptable. A significant portion of these products were acquired through direct purchases, rather than going through public tenders, which undermines the ability to secure the best products at the best prices. The challenge moving forward is to reverse this trend. The country must prioritize public tenders, optimize spending, and ensure it gets maximum value for every peso spent.

Read the full article here.